1. |
Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med, 2006, 355(13): 1345-1356.
|
2. |
Nicola S, Giusy CP, Luca P, et al. Current role of surgery for tuberous sclerosis complex-associated epilepsy. Pediatr Investig, 2022, 6(1): 16-22.
|
3. |
Nicola S, Chiara P, Luca P, et al. Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what. Epileptic Disorders, 2021, 23(1): 53-73.
|
4. |
Holmes GL, Stafstrom CE. Tuberous Sclerosis Study Group. Tuberous sclerosis complex and epilepsy: recent developments andfuture challenges. Epilepsia, 2007, 48(4): 617-630.
|
5. |
van Slegtenhorst M, Nellist M, Nagelkerken B, et al. Interaction betweenhamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet, 1998, 7(6): 1053-1057.
|
6. |
Katarzyna K, Krinio G, Joannes MG, et al. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex. Am J Hum Genet, 2023, 110(6): 979-988.
|
7. |
Magdalena ET, Kira AD, Jennifer G, et al. Mosaic and intronic mutations in TSC1/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet, 2015, 11(11): e1005637.
|
8. |
Laura SF , Deborah AP, John PW, et al. Tuberous sclerosis complex genotypes and developmental phenotype. Pediatric Neurology, 2019, 96: 58-63.
|
9. |
Ding Yf , Zhou Yf, Yu Lf, et al . Correlation between epilepsy and genotype: a large retrospective tuberous sclerosis complex cohort. Seizure, 2021, 91: 273–277.
|
10. |
Angela P, Aglaia V, Francesca LB, et al. Deep phenotyping of patients with tuberous sclerosis complex and no mutation identified in TSC1 and TSC2. Eur J Med Genet, 2018, 61(7): 403-410.
|
11. |
Black, ME, Hedgire, SS, Camposano, S, et al. Hepatic manifestations of tuberous sclerosis complex: a genotypic and phenotypic analysis. Clinical Genetics, 2012, 82: 552-557.
|
12. |
Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet, 2001, 68(1): 64-80.
|
13. |
Au KS, Williams AT, Roach ES, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med, 2007, 9: 88-100.
|
14. |
Camposano SE, Greenberg E, Kwiatkowski DJ, et al. Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified. Ann Hum Genet, 2009, 73(2): 141-146.
|
15. |
Aria F, Shaun DR, Alexander GW, et al. Resective epilepsy surgery for tuberous sclerosis in children: determining predictors of seizure outcomes in a multicenter retrospective cohort study. Neurosurgery, 2015, 77(4): 517-524.
|